+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

NRT Smoking Cessation Aids in Singapore

  • PDF Icon

    Report

  • 22 Pages
  • September 2022
  • Region: Singapore
  • Euromonitor International
  • ID: 4432192
As restrictions on group sizes and outdoor activities were lifted in April 2022, increasing numbers of employees in Singapore returned to the office for work. According to to the Voice of the Consumer: Nicotine survey, smoking increased among people living with rising anxiety during the pandemic. The seemingly unending nature of the pandemic, as well as financial and job security concerns, drove up smoking among some local citizens, including those that were initially inte...

The NRT Smoking Cessation Aids in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the NRT Smoking Cessation Aids market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

NRT SMOKING CESSATION AIDS IN SINGAPOREKEY DATA FINDINGS
2022 DEVELOPMENTS
  • Easing of pandemic-related outdoor restrictions leads to mild drop in adult smoking population
  • Government regulations on smoking serve to quell higher smoking rates
  • Public service campaigns encourage use of nicotine replacement therapy to quit smoking
PROSPECTS AND OPPORTUNITIES
  • Role of NRT smoking cessation aids uncertain amid possibility of smoking cohort ban
  • Large pharmaceutical companies maintain their leading positions
CATEGORY INDICATORS
  • Table 1 Number of Smokers by Gender 2017-2022
CATEGORY DATA
  • Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
  • Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
  • Table 4 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2018-2022
  • Table 5 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2019-2022
  • Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2022-2027
  • Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN SINGAPORE
EXECUTIVE SUMMARY
  • Consumer health in 2022: The big picture
  • 2022 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
  • Table 9 Life Expectancy at Birth 2017-2022
MARKET DATA
  • Table 10 Sales of Consumer Health by Category: Value 2017-2022
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2017-2022
  • Table 12 NBO Company Shares of Consumer Health: % Value 2018-2022
  • Table 13 LBN Brand Shares of Consumer Health: % Value 2019-2022
  • Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
  • Table 15 Distribution of Consumer Health by Format: % Value 2017-2022
  • Table 16 Distribution of Consumer Health by Format and Category: % Value 2022
  • Table 17 Forecast Sales of Consumer Health by Category: Value 2022-2027
  • Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources